Epilog

Epilog

Private
BelgiumHealthcare & Life Scienceshttps://www.cloudsofcare.com/index.html

Last Round

Series A

Extension

Jun 27, 2025

Est. Valuation

$918,000

Total Funding Raised

$9.13M

Momentum Score

25 /100

Company Overview

Epilog is a MedTech company, operating as a business unit of Clouds of Care, that provides an AI-powered service for EEG diagnostics to assist in the evaluation of epilepsy.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

EEG analysisepilepsy diagnosisseizure source localizationelectrical source imagingESIsoftware as a medical deviceSaMDclinical AIneurotechclinical trial servicesdigital biomarkersCNS clinical trialsbrain wave analysissleep disorder analysisFDA clearedCE markedpreoperative evaluation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epilog Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Epilog Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJun 27, 2025
Series ASep 4, 2024
SeedJun 30, 2021
AcceleratorOct 12, 2016

Key People

Founding team and executive leadership

Pieter van Mierlo

Chief Scientific Officer, Co-founder & Director, Co-founder

Founding Team

Gregor Strobbe

Chief Executive Officer, Founder Director

Founding Team

Jurgen Van Broeck

Partner Advisor Clouds Of Care, CEO At Somnilog And Director Kreivo Health

Executive Team

Tom Van Steenkiste

CTO

Executive Team

Epilog Investors

Notable investors and investment history

InvestorRounds
imec.istartAccelerator
White FundSeries A, Series A Extension
Flanders Future Tech FundSeries A, Series A Extension
PMVSeed
Novalis Biotech Acceleration FundSeries A Extension
TCD CapitalSeries A Extension, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 42% QoQ, from 43 to 61 employees.

  • Jun 27, 2025

    Raised $2.34M led by Novalis Biotech Acceleration Fund

Epilog Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epilog Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epilog's valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range61
Year Founded2016
Last FundingJun 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.